Creative Biolabs has invited Dr. Archana Thakur and Dr. Luca Varani to walk us through how they utilize the power of bsAbs to 1) arm "headless CAR T cells" and serially kill tumor targets and 2) neutralize wild-type SARS-CoV-2 and its variants and suppress viral escape.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virus therapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virus therapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virus therapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Here is a brief introduction to lentiviral vector gene delivery system and its applications in CAR-T cell construction.

Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Today, we are going to share some basic knowledge about Chimeric Antigen Receptor or CAR technology and its applications in tumor therapy.

Here, we will introduce the virus and its pathogenic mechanism in detail. At the same time, you will learn how to obtain functional anti-virus antibodies and peptides through our technology platform.

In this episode, we will study the overview of membrane protein and membrane protein antibody.